{"id":187980,"name":"NEUROS MEDICAL, INC.","slug":"neuros-medical-inc","state":"OH","country":"United States of America","description":"Neuromodulation","totalSpending":160000,"filings":17,"yearlySpending":[{"year":2019,"income":30000},{"year":2020,"income":40000},{"year":2021,"income":40000},{"year":2022,"income":50000}],"issues":["HCR","MMM"],"firms":["GALILEO CONSULTING GROUP, INC."],"lobbyists":["JILL RATHBUN"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to Medicare reimbursement for opioid-alternative treatments for chronic pain; Federal support and policies regarding better therapies for chronic pain","Issues related to Medicare reimbursement for opioid-alternative treatments for chronic pain; Federal support and policies regarding better therapies for chronic pain","-- Federal support and policies regarding better therapies for chronic pain\n\n-- Obtain congressional delegation letter to address technologies involved in chronic pain management without opioids","-- Issues related to Medicare reimbursement for opioid-alternative treatments for chronic pain\n\n-- Obtain congressional delegation letter to address the New Technology Ambulatory Payment Classificatio","-- Issues related to Medicare reimbursement for opioid-alternative treatments for chronic pain."],"years":[2019,2020,2021,2022]}